Skip to main content

Peer Review reports

From: Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: study protocol for a randomized controlled trial

Original Submission
20 Mar 2018 Submitted Original manuscript
17 Jul 2018 Author responded Author comments - Yuerong JIANG
Resubmission - Version 2
17 Jul 2018 Submitted Manuscript version 2
13 Jan 2019 Author responded Author comments - Yuerong JIANG
Resubmission - Version 3
13 Jan 2019 Submitted Manuscript version 3
29 Jan 2019 Reviewed Reviewer Report - Robby Nieuwlaat
31 Jan 2019 Reviewed Reviewer Report - Noah Ivers
1 Feb 2019 Reviewed Reviewer Report - JD Schwalm
9 Feb 2019 Author responded Author comments - Yuerong JIANG
Resubmission - Version 4
9 Feb 2019 Submitted Manuscript version 4
Publishing
19 Mar 2019 Editorially accepted
15 Apr 2019 Article published 10.1186/s13063-019-3308-5

You can find further information about peer review here.

Back to article page